| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gene Editing | 17 | 2026 | 230 | 4.070 |
Why?
|
| Dependovirus | 17 | 2026 | 161 | 3.050 |
Why?
|
| CRISPR-Cas Systems | 13 | 2026 | 317 | 2.800 |
Why?
|
| Genetic Vectors | 14 | 2026 | 900 | 2.460 |
Why?
|
| Liver | 19 | 2025 | 1802 | 1.930 |
Why?
|
| Genetic Therapy | 12 | 2025 | 718 | 1.800 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 4 | 2020 | 85 | 1.720 |
Why?
|
| Receptors, LDL | 6 | 2018 | 105 | 1.300 |
Why?
|
| Atherosclerosis | 7 | 2023 | 949 | 1.240 |
Why?
|
| Lipid Metabolism | 5 | 2019 | 370 | 1.240 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 4 | 2020 | 32 | 1.210 |
Why?
|
| Hepatocytes | 6 | 2025 | 235 | 1.180 |
Why?
|
| Apolipoproteins | 5 | 2014 | 70 | 1.160 |
Why?
|
| Metabolic Diseases | 2 | 2023 | 140 | 1.150 |
Why?
|
| Lipoprotein(a) | 2 | 2026 | 140 | 1.040 |
Why?
|
| Gene Targeting | 3 | 2025 | 170 | 0.970 |
Why?
|
| Animals | 54 | 2026 | 33829 | 0.950 |
Why?
|
| Cytosine | 1 | 2026 | 58 | 0.940 |
Why?
|
| Cardiovascular Diseases | 4 | 2022 | 2096 | 0.930 |
Why?
|
| Mice | 38 | 2026 | 18174 | 0.900 |
Why?
|
| Genes, Essential | 1 | 2025 | 40 | 0.880 |
Why?
|
| Viral Tropism | 1 | 2025 | 47 | 0.860 |
Why?
|
| Sequence Deletion | 2 | 2026 | 519 | 0.840 |
Why?
|
| Transgenes | 5 | 2025 | 320 | 0.830 |
Why?
|
| Cholesterol, HDL | 6 | 2017 | 394 | 0.810 |
Why?
|
| Hypercholesterolemia | 3 | 2022 | 234 | 0.740 |
Why?
|
| Terpenes | 1 | 2020 | 32 | 0.660 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2020 | 123 | 0.660 |
Why?
|
| Cholesterol | 9 | 2023 | 540 | 0.650 |
Why?
|
| Hyperlipidemias | 1 | 2022 | 189 | 0.630 |
Why?
|
| Lipids | 4 | 2019 | 563 | 0.630 |
Why?
|
| Mice, Knockout | 14 | 2023 | 3828 | 0.550 |
Why?
|
| Lipoproteins, HDL | 4 | 2017 | 97 | 0.540 |
Why?
|
| Stem Cells | 2 | 2022 | 708 | 0.540 |
Why?
|
| Intestines | 1 | 2022 | 590 | 0.540 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 242 | 0.530 |
Why?
|
| Gene Transfer Techniques | 4 | 2019 | 342 | 0.520 |
Why?
|
| Promoter Regions, Genetic | 6 | 2020 | 1213 | 0.490 |
Why?
|
| Carrier Proteins | 3 | 2021 | 1017 | 0.480 |
Why?
|
| Disease Models, Animal | 9 | 2025 | 4647 | 0.470 |
Why?
|
| Dyslipidemias | 1 | 2019 | 250 | 0.470 |
Why?
|
| Phospholipid Transfer Proteins | 2 | 2017 | 16 | 0.460 |
Why?
|
| Mice, Inbred C57BL | 15 | 2025 | 4689 | 0.450 |
Why?
|
| Genome | 1 | 2017 | 467 | 0.430 |
Why?
|
| Spasms, Infantile | 1 | 2016 | 165 | 0.420 |
Why?
|
| STAT2 Transcription Factor | 1 | 2014 | 3 | 0.420 |
Why?
|
| Interferon Type I | 1 | 2014 | 114 | 0.390 |
Why?
|
| Capsid | 2 | 2023 | 95 | 0.390 |
Why?
|
| Lipoproteins | 2 | 2015 | 183 | 0.380 |
Why?
|
| Mice, Transgenic | 9 | 2026 | 2332 | 0.370 |
Why?
|
| Adenoviridae | 4 | 2026 | 580 | 0.370 |
Why?
|
| Membrane Proteins | 2 | 2019 | 1599 | 0.300 |
Why?
|
| Electroporation | 1 | 2007 | 36 | 0.260 |
Why?
|
| Humans | 27 | 2026 | 130599 | 0.250 |
Why?
|
| Apolipoproteins B | 3 | 2023 | 144 | 0.250 |
Why?
|
| Gene Expression | 4 | 2020 | 1488 | 0.240 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2018 | 3410 | 0.240 |
Why?
|
| Male | 21 | 2025 | 64580 | 0.230 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 2 | 2018 | 241 | 0.230 |
Why?
|
| Fatty Acids | 2 | 2019 | 378 | 0.220 |
Why?
|
| Hydrolases | 1 | 2025 | 61 | 0.220 |
Why?
|
| Serogroup | 1 | 2025 | 63 | 0.220 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 240 | 0.210 |
Why?
|
| Tissue Distribution | 1 | 2025 | 364 | 0.210 |
Why?
|
| Plasmids | 4 | 2018 | 451 | 0.210 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2005 | 143 | 0.210 |
Why?
|
| Myotonic Dystrophy | 1 | 2025 | 73 | 0.210 |
Why?
|
| Transduction, Genetic | 1 | 2025 | 279 | 0.210 |
Why?
|
| Signal Transduction | 3 | 2021 | 4659 | 0.200 |
Why?
|
| Myocytes, Cardiac | 2 | 2019 | 675 | 0.200 |
Why?
|
| Glutaryl-CoA Dehydrogenase | 1 | 2023 | 4 | 0.200 |
Why?
|
| Mutation | 6 | 2018 | 6138 | 0.190 |
Why?
|
| Phospholipids | 3 | 2014 | 103 | 0.190 |
Why?
|
| Hyperlipoproteinemia Type II | 2 | 2015 | 121 | 0.190 |
Why?
|
| Lysine | 1 | 2023 | 165 | 0.190 |
Why?
|
| Blood-Brain Barrier | 1 | 2023 | 150 | 0.190 |
Why?
|
| Gene Deletion | 2 | 2020 | 766 | 0.190 |
Why?
|
| Sterols | 1 | 2022 | 16 | 0.180 |
Why?
|
| Acyl Coenzyme A | 1 | 2022 | 23 | 0.180 |
Why?
|
| Lipase | 2 | 2014 | 88 | 0.180 |
Why?
|
| Chondrogenesis | 1 | 2021 | 30 | 0.180 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2023 | 202 | 0.180 |
Why?
|
| Muscles | 1 | 2021 | 204 | 0.170 |
Why?
|
| DNA Repair | 1 | 2025 | 580 | 0.170 |
Why?
|
| Cells | 1 | 2021 | 20 | 0.170 |
Why?
|
| Cilia | 1 | 2021 | 79 | 0.170 |
Why?
|
| RNA-Binding Proteins | 1 | 2025 | 543 | 0.170 |
Why?
|
| Mevalonic Acid | 1 | 2020 | 20 | 0.170 |
Why?
|
| Limb Deformities, Congenital | 1 | 2021 | 117 | 0.170 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2021 | 135 | 0.170 |
Why?
|
| Trans-Activators | 2 | 2018 | 683 | 0.170 |
Why?
|
| Osteogenesis | 1 | 2021 | 165 | 0.160 |
Why?
|
| Autoimmune Diseases | 1 | 2023 | 265 | 0.160 |
Why?
|
| Phenotype | 6 | 2025 | 4469 | 0.160 |
Why?
|
| Gene Order | 1 | 2020 | 82 | 0.160 |
Why?
|
| Myocardium | 1 | 2025 | 865 | 0.160 |
Why?
|
| Biological Transport | 4 | 2017 | 332 | 0.160 |
Why?
|
| Diet, Western | 1 | 2019 | 20 | 0.160 |
Why?
|
| Muscle, Skeletal | 2 | 2017 | 998 | 0.150 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2019 | 32 | 0.150 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2019 | 20 | 0.150 |
Why?
|
| Luciferases | 4 | 2009 | 125 | 0.150 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2019 | 31 | 0.150 |
Why?
|
| Female | 12 | 2025 | 70540 | 0.150 |
Why?
|
| Immunophenotyping | 1 | 2020 | 333 | 0.150 |
Why?
|
| Heat-Shock Proteins | 1 | 2020 | 175 | 0.150 |
Why?
|
| Natriuretic Peptide, C-Type | 1 | 2019 | 15 | 0.150 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2020 | 198 | 0.150 |
Why?
|
| RNAi Therapeutics | 1 | 2019 | 17 | 0.150 |
Why?
|
| Immunization | 1 | 2020 | 266 | 0.140 |
Why?
|
| Exons | 2 | 2023 | 761 | 0.140 |
Why?
|
| Immunologic Memory | 1 | 2020 | 194 | 0.140 |
Why?
|
| Gene Knock-In Techniques | 1 | 2019 | 119 | 0.140 |
Why?
|
| Cell Lineage | 1 | 2020 | 345 | 0.140 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2019 | 72 | 0.140 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2020 | 198 | 0.140 |
Why?
|
| Protein Precursors | 1 | 2019 | 141 | 0.140 |
Why?
|
| Myocardial Infarction | 2 | 2019 | 1002 | 0.140 |
Why?
|
| Argininosuccinate Lyase | 1 | 2018 | 62 | 0.140 |
Why?
|
| Proprotein Convertase 9 | 1 | 2018 | 110 | 0.140 |
Why?
|
| Regeneration | 1 | 2020 | 231 | 0.130 |
Why?
|
| Rats | 5 | 2023 | 3407 | 0.130 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 376 | 0.130 |
Why?
|
| Monocytes | 1 | 2019 | 335 | 0.130 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2018 | 81 | 0.130 |
Why?
|
| Genes, Reporter | 3 | 2019 | 340 | 0.130 |
Why?
|
| Genome, Human | 2 | 2021 | 1317 | 0.130 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 658 | 0.120 |
Why?
|
| Phenylbutyrates | 1 | 2017 | 55 | 0.120 |
Why?
|
| Apoptosis | 2 | 2020 | 1849 | 0.120 |
Why?
|
| Mutagenesis, Insertional | 1 | 2017 | 151 | 0.120 |
Why?
|
| Heart Atria | 1 | 2019 | 336 | 0.120 |
Why?
|
| Cholesterol Esters | 1 | 2015 | 11 | 0.120 |
Why?
|
| Sex Characteristics | 1 | 2018 | 328 | 0.120 |
Why?
|
| RNA Splice Sites | 1 | 2016 | 92 | 0.120 |
Why?
|
| Phosphoproteins | 1 | 2018 | 430 | 0.120 |
Why?
|
| Tachycardia, Ventricular | 1 | 2018 | 255 | 0.120 |
Why?
|
| CD36 Antigens | 1 | 2015 | 35 | 0.120 |
Why?
|
| Mitochondria, Muscle | 1 | 2015 | 37 | 0.110 |
Why?
|
| Calcium Channels, L-Type | 1 | 2015 | 49 | 0.110 |
Why?
|
| Cell Proliferation | 2 | 2020 | 2472 | 0.110 |
Why?
|
| Germ-Line Mutation | 1 | 2017 | 373 | 0.110 |
Why?
|
| Peptide Hydrolases | 1 | 2015 | 131 | 0.110 |
Why?
|
| Gene Expression Regulation | 4 | 2017 | 2337 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2023 | 587 | 0.110 |
Why?
|
| Macrophages | 4 | 2017 | 651 | 0.110 |
Why?
|
| Apolipoprotein A-I | 2 | 2011 | 80 | 0.110 |
Why?
|
| Calcium | 2 | 2017 | 1033 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2007 | 1135 | 0.100 |
Why?
|
| Bile Acids and Salts | 1 | 2015 | 259 | 0.100 |
Why?
|
| Anticholesteremic Agents | 1 | 2015 | 241 | 0.100 |
Why?
|
| Muscle Proteins | 3 | 2023 | 403 | 0.100 |
Why?
|
| HEK293 Cells | 2 | 2014 | 806 | 0.100 |
Why?
|
| Aorta | 2 | 2014 | 524 | 0.100 |
Why?
|
| Base Sequence | 1 | 2017 | 2746 | 0.100 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 1837 | 0.090 |
Why?
|
| Pedigree | 1 | 2016 | 1677 | 0.090 |
Why?
|
| Capsid Proteins | 2 | 2023 | 148 | 0.090 |
Why?
|
| Calcium Signaling | 3 | 2019 | 245 | 0.090 |
Why?
|
| beta-Galactosidase | 1 | 2012 | 134 | 0.090 |
Why?
|
| Glycosylation | 1 | 2012 | 125 | 0.090 |
Why?
|
| Molecular Weight | 1 | 2012 | 279 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 915 | 0.090 |
Why?
|
| Cholesterol, LDL | 2 | 2015 | 616 | 0.090 |
Why?
|
| Protein Binding | 3 | 2020 | 1658 | 0.090 |
Why?
|
| Staining and Labeling | 1 | 2012 | 167 | 0.090 |
Why?
|
| Adipose Tissue | 1 | 2014 | 494 | 0.080 |
Why?
|
| Transfection | 3 | 2009 | 946 | 0.080 |
Why?
|
| Thyroid Hormones | 1 | 2011 | 53 | 0.080 |
Why?
|
| Biomarkers | 1 | 2020 | 3395 | 0.080 |
Why?
|
| Triglycerides | 2 | 2014 | 605 | 0.080 |
Why?
|
| SOX9 Transcription Factor | 2 | 2021 | 89 | 0.080 |
Why?
|
| Genotype | 1 | 2016 | 2609 | 0.080 |
Why?
|
| Vasodilation | 1 | 2011 | 175 | 0.080 |
Why?
|
| Diet, High-Fat | 1 | 2012 | 263 | 0.080 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2011 | 191 | 0.080 |
Why?
|
| Insulin | 2 | 2005 | 1146 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 356 | 0.080 |
Why?
|
| Carotid Artery Diseases | 1 | 2010 | 132 | 0.080 |
Why?
|
| Lipoproteins, HDL2 | 1 | 2009 | 2 | 0.080 |
Why?
|
| Lipoproteins, HDL3 | 1 | 2009 | 2 | 0.080 |
Why?
|
| Octamer Transcription Factor-1 | 1 | 2009 | 3 | 0.080 |
Why?
|
| Heart Failure | 2 | 2019 | 2316 | 0.070 |
Why?
|
| DNA-Binding Proteins | 2 | 2025 | 1948 | 0.070 |
Why?
|
| Retinoblastoma Protein | 1 | 2009 | 78 | 0.070 |
Why?
|
| Alanine Transaminase | 1 | 2008 | 156 | 0.070 |
Why?
|
| Response Elements | 2 | 2005 | 104 | 0.070 |
Why?
|
| Neurons | 1 | 2018 | 1988 | 0.070 |
Why?
|
| Cloning, Molecular | 1 | 2008 | 779 | 0.070 |
Why?
|
| Down-Regulation | 2 | 2020 | 650 | 0.070 |
Why?
|
| Lovastatin | 1 | 2007 | 26 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2020 | 824 | 0.060 |
Why?
|
| Bone Marrow | 1 | 2008 | 314 | 0.060 |
Why?
|
| Microsomes, Liver | 1 | 2007 | 96 | 0.060 |
Why?
|
| Antioxidants | 1 | 2009 | 334 | 0.060 |
Why?
|
| Feeding Behavior | 1 | 2012 | 717 | 0.060 |
Why?
|
| DNA Footprinting | 1 | 2005 | 13 | 0.060 |
Why?
|
| CCAAT-Binding Factor | 1 | 2005 | 6 | 0.060 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2005 | 53 | 0.060 |
Why?
|
| Cholesterol, Dietary | 1 | 2005 | 48 | 0.060 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2005 | 98 | 0.060 |
Why?
|
| Myotonin-Protein Kinase | 1 | 2025 | 26 | 0.060 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2005 | 230 | 0.060 |
Why?
|
| Proteomics | 1 | 2009 | 602 | 0.050 |
Why?
|
| Cell Line | 1 | 2008 | 2569 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2010 | 1558 | 0.050 |
Why?
|
| Apoprotein(a) | 1 | 2023 | 6 | 0.050 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2023 | 66 | 0.050 |
Why?
|
| Apolipoprotein B-100 | 1 | 2023 | 36 | 0.050 |
Why?
|
| Cell Differentiation | 2 | 2021 | 1919 | 0.050 |
Why?
|
| Apolipoproteins A | 1 | 2023 | 53 | 0.050 |
Why?
|
| Brain Diseases, Metabolic | 1 | 2023 | 16 | 0.050 |
Why?
|
| Immunoprecipitation | 1 | 2023 | 189 | 0.050 |
Why?
|
| Obesity | 3 | 2023 | 2389 | 0.050 |
Why?
|
| Alternative Splicing | 1 | 2025 | 308 | 0.050 |
Why?
|
| Muscle Weakness | 1 | 2023 | 88 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2019 | 12901 | 0.050 |
Why?
|
| Cell Line, Tumor | 4 | 2015 | 3696 | 0.050 |
Why?
|
| Endothelium, Vascular | 2 | 2019 | 466 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2009 | 1215 | 0.050 |
Why?
|
| Endothelium | 1 | 2022 | 62 | 0.050 |
Why?
|
| Oxidation-Reduction | 2 | 2015 | 432 | 0.050 |
Why?
|
| APOBEC-1 Deaminase | 2 | 2012 | 11 | 0.050 |
Why?
|
| Cytidine Deaminase | 2 | 2012 | 31 | 0.050 |
Why?
|
| Kidney | 1 | 2008 | 1285 | 0.040 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2023 | 112 | 0.040 |
Why?
|
| Cartilage | 1 | 2021 | 52 | 0.040 |
Why?
|
| Energy Metabolism | 2 | 2018 | 794 | 0.040 |
Why?
|
| Chondrocytes | 1 | 2021 | 48 | 0.040 |
Why?
|
| Kinetics | 2 | 2015 | 1088 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2023 | 274 | 0.040 |
Why?
|
| Models, Biological | 2 | 2020 | 1391 | 0.040 |
Why?
|
| Infant | 1 | 2016 | 13302 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 1380 | 0.040 |
Why?
|
| Fibroblast Growth Factors | 1 | 2021 | 171 | 0.040 |
Why?
|
| Goals | 1 | 2021 | 125 | 0.040 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2021 | 208 | 0.040 |
Why?
|
| Spheroids, Cellular | 1 | 2020 | 59 | 0.040 |
Why?
|
| Bile Ducts | 1 | 2020 | 53 | 0.040 |
Why?
|
| Peptides | 1 | 2023 | 709 | 0.040 |
Why?
|
| Bone and Bones | 1 | 2021 | 297 | 0.040 |
Why?
|
| Lipoproteins, LDL | 1 | 2019 | 118 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2009 | 2438 | 0.040 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2019 | 43 | 0.040 |
Why?
|
| Heart | 1 | 2023 | 666 | 0.040 |
Why?
|
| Immunoblotting | 2 | 2012 | 291 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2019 | 142 | 0.040 |
Why?
|
| Cholangiocarcinoma | 1 | 2020 | 127 | 0.040 |
Why?
|
| Bile Duct Neoplasms | 1 | 2020 | 131 | 0.040 |
Why?
|
| Receptors, Leptin | 1 | 2018 | 41 | 0.030 |
Why?
|
| Oxidoreductases | 1 | 2018 | 103 | 0.030 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 1 | 2018 | 41 | 0.030 |
Why?
|
| Calsequestrin | 1 | 2017 | 12 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2020 | 503 | 0.030 |
Why?
|
| Recombinational DNA Repair | 1 | 2017 | 17 | 0.030 |
Why?
|
| High-Density Lipoproteins, Pre-beta | 1 | 2017 | 1 | 0.030 |
Why?
|
| Public Opinion | 1 | 2017 | 63 | 0.030 |
Why?
|
| Hypothalamus | 1 | 2018 | 203 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2017 | 362 | 0.030 |
Why?
|
| Hepatitis B virus | 1 | 2017 | 137 | 0.030 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2019 | 359 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2017 | 331 | 0.030 |
Why?
|
| Risk Factors | 1 | 2010 | 10991 | 0.030 |
Why?
|
| Action Potentials | 1 | 2018 | 466 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2015 | 139 | 0.030 |
Why?
|
| Estrogens | 1 | 2018 | 431 | 0.030 |
Why?
|
| Heart Rate | 1 | 2018 | 579 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2015 | 187 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 1 | 2015 | 167 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 2935 | 0.030 |
Why?
|
| Heterografts | 1 | 2015 | 192 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2015 | 138 | 0.030 |
Why?
|
| Plasmalogens | 1 | 2014 | 7 | 0.030 |
Why?
|
| Phospholipases A2 | 1 | 2014 | 30 | 0.030 |
Why?
|
| Diglycerides | 1 | 2014 | 16 | 0.030 |
Why?
|
| Sex Factors | 1 | 2018 | 1338 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 514 | 0.030 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2014 | 112 | 0.030 |
Why?
|
| Body Weight | 1 | 2018 | 989 | 0.030 |
Why?
|
| Homeostasis | 1 | 2018 | 712 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2014 | 156 | 0.030 |
Why?
|
| Adiponectin | 1 | 2014 | 124 | 0.030 |
Why?
|
| United States | 2 | 2021 | 11814 | 0.030 |
Why?
|
| Lung | 1 | 2021 | 1572 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2014 | 397 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2017 | 791 | 0.020 |
Why?
|
| Enzyme-Linked Immunospot Assay | 1 | 2012 | 9 | 0.020 |
Why?
|
| Leptin | 1 | 2014 | 217 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2017 | 798 | 0.020 |
Why?
|
| Mitochondria | 1 | 2017 | 761 | 0.020 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2011 | 16 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 2011 | 63 | 0.020 |
Why?
|
| Particle Size | 1 | 2011 | 137 | 0.020 |
Why?
|
| Cricetinae | 1 | 2011 | 363 | 0.020 |
Why?
|
| Lipoproteins, VLDL | 1 | 2010 | 53 | 0.020 |
Why?
|
| Lipogenesis | 1 | 2010 | 62 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2012 | 538 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2010 | 152 | 0.020 |
Why?
|
| Centrifugation, Isopycnic | 1 | 2009 | 1 | 0.020 |
Why?
|
| Esterases | 1 | 2009 | 12 | 0.020 |
Why?
|
| Aryldialkylphosphatase | 1 | 2009 | 9 | 0.020 |
Why?
|
| Apolipoprotein L1 | 1 | 2009 | 13 | 0.020 |
Why?
|
| Regulatory Factor X Transcription Factors | 1 | 2009 | 10 | 0.020 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2009 | 61 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 528 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 1007 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2009 | 238 | 0.020 |
Why?
|
| Heterozygote | 1 | 2010 | 721 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 4022 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2014 | 899 | 0.020 |
Why?
|
| Wound Healing | 1 | 2010 | 476 | 0.020 |
Why?
|
| Binding Sites | 1 | 2009 | 1144 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2011 | 2902 | 0.010 |
Why?
|
| Pregnancy | 1 | 2017 | 7495 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2010 | 2557 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2017 | 8554 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2004 | 229 | 0.010 |
Why?
|
| Child | 1 | 2015 | 26182 | 0.010 |
Why?
|